Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Henan Ocular Pharmacology and Therapeutics International Laboratory, |
RCV001293654 | SCV001482302 | pathogenic | Retinitis pigmentosa | criteria provided, single submitter | research | ||
Labcorp Genetics |
RCV001363129 | SCV001559228 | uncertain significance | not provided | 2023-12-15 | criteria provided, single submitter | clinical testing | This sequence change replaces cysteine, which is neutral and slightly polar, with phenylalanine, which is neutral and non-polar, at codon 118 of the ARL3 protein (p.Cys118Phe). This variant is present in population databases (rs551366324, gnomAD 0.1%). This missense change has been observed in individual(s) with clinical features of ARL3-related conditions (PMID: 33748123). ClinVar contains an entry for this variant (Variation ID: 997972). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change affects ARL3 function (PMID: 33748123). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Dept Of Ophthalmology, |
RCV003887991 | SCV004706951 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research |